Please provide your email address to receive an email when new articles are posted on . Rezpegaldesleukin is an interleukin-2 receptor pathway agonist that has shown success in other autoimmune ...
A phase 2 trial evaluating CS-1103 in participants with methamphetamine use disorder is expected to begin in the first quarter of 2026. The Food and Drug Administration (FDA) has granted Fast Track ...
ABBV-CLS-628 is currently being evaluated in a phase 2 trial in an estimated 240 adults with ADPKD class 1C, 1D, or 1E. The Food and Drug Administration (FDA) has granted Fast Track designation to ...
The FDA's fast track designation for muzastotug with Keytruda targets microsatellite stable metastatic colorectal cancer without liver metastases, based on promising early clinical evidence.
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. ADX-2191 is an intravitreal formulation of methotrexate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results